A new trading day began on Tuesday, with GlycoMimetics Inc (NASDAQ: GLYC) stock price down -2.82% from the previous day of trading, before settling in for the closing price of $0.16. GLYC’s price has ranged from $0.16 to $3.53 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -53.76% over the last five years. Meanwhile, its annual earnings per share averaged -4.74%. With a float of $59.08 million, this company’s outstanding shares have now reached $64.39 million.
The firm has a total of 35 workers. Let’s measure their productivity. In terms of profitability, gross margin is -3102.77%, operating margin of -98445597.2%, and the pretax margin is -391140.73%.
GlycoMimetics Inc (GLYC) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of GlycoMimetics Inc is 8.38%, while institutional ownership is 35.46%. The most recent insider transaction that took place on Aug 08 ’24, was worth 50,009. In this transaction 10% Owner of this company sold 260,873 shares at a rate of $0.19, taking the stock ownership to the 6,317,565 shares. Before that another transaction happened on Aug 07 ’24, when Company’s 10% Owner sold 61,488 for $0.18, making the entire transaction worth $11,197. This insider now owns 6,578,438 shares in total.
GlycoMimetics Inc (GLYC) Recent Fiscal highlights
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.14 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -4.74% per share during the next fiscal year.
GlycoMimetics Inc (NASDAQ: GLYC) Trading Performance Indicators
Here are GlycoMimetics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1023.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.61, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.43 in one year’s time.
Technical Analysis of GlycoMimetics Inc (GLYC)
Analysing the last 5-days average volume posted by the [GlycoMimetics Inc, GLYC], we can find that recorded value of 0.46 million was lower than the volume posted last year of 2.08 million. As of the previous 9 days, the stock’s Stochastic %D was 13.28%. Additionally, its Average True Range was 0.02.
During the past 100 days, GlycoMimetics Inc’s (GLYC) raw stochastic average was set at 0.17%, which indicates a significant decrease from 7.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.23% in the past 14 days, which was lower than the 293.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2222, while its 200-day Moving Average is $1.5387. Now, the first resistance to watch is $0.1641. This is followed by the second major resistance level at $0.1694. The third major resistance level sits at $0.1730. If the price goes on to break the first support level at $0.1552, it is likely to go to the next support level at $0.1516. Now, if the price goes above the second support level, the third support stands at $0.1463.
GlycoMimetics Inc (NASDAQ: GLYC) Key Stats
With a market capitalization of 10.23 million, the company has a total of 64,464K Shares Outstanding. Currently, annual sales are 10 K while annual income is -36,900 K. The company’s previous quarter sales were 0 K while its latest quarter income was -10,740 K.
